Literature DB >> 19374905

Human CD1 dimeric proteins as indispensable tools for research on CD1-binding lipids and CD1-restricted T cells.

Takayuki Shiratsuchi1, Jonathan Schneck, Akira Kawamura, Moriya Tsuji.   

Abstract

Antigen presenting molecules play an important role in both innate and adoptive immune responses by priming and activating T cells. Among them, CD1 molecules have been identified to present both exogenous and endogenous lipid antigens to CD1-restricted T cells. The involvement of CD1-restricted T cells in autoimmune diseases and in defense against infectious diseases, however, remains largely unknown. Identifying novel antigenic lipids that bind to CD1 molecules and understanding the role of CD1-restricted T cells should lead to the successful development of vaccines, because the lipids can be used as antigens and also as adjuvants. In this paper, we have constructed functional recombinant human CD1 dimeric proteins and established a competitive ELISA assay to measure the lipid binding to CD1 molecules using the CD1 dimers. By using the competitive ELISA assay, we were able to show that the lipid extracts from murine malaria parasites can actually be loaded onto CD1 molecules. In addition, we have demonstrated that artificial antigen-presenting cells, which consist of magnetic beads coated with CD1d dimer and anti-CD28 antibody, stimulated and expanded human invariant NKT cells as efficiently as autologous immature DCs. A set of the tools presented in the current study should be valuable for screening various CD1 molecule-binding lipid antigens and for isolating CD1-restricted T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374905      PMCID: PMC2743114          DOI: 10.1016/j.jim.2009.04.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  47 in total

Review 1.  Harnessing invariant NKT cells in vaccination strategies.

Authors:  Vincenzo Cerundolo; Jonathan D Silk; S Hajar Masri; Mariolina Salio
Journal:  Nat Rev Immunol       Date:  2009-01       Impact factor: 53.106

2.  Glycolipid antigen processing for presentation by CD1d molecules.

Authors:  T I Prigozy; O Naidenko; P Qasba; D Elewaut; L Brossay; A Khurana; T Natori; Y Koezuka; A Kulkarni; M Kronenberg
Journal:  Science       Date:  2001-01-26       Impact factor: 47.728

3.  Conservation of a CD1 multigene family in the guinea pig.

Authors:  C C Dascher; K Hiromatsu; J W Naylor; P P Brauer; K A Brown; J R Storey; S M Behar; E S Kawasaki; S A Porcelli; M B Brenner; K P LeClair
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

4.  CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection.

Authors:  D B Moody; T Ulrichs; W Mühlecker; D C Young; S S Gurcha; E Grant; J P Rosat; M B Brenner; C E Costello; G S Besra; S A Porcelli
Journal:  Nature       Date:  2000-04-20       Impact factor: 49.962

5.  Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes.

Authors:  S Sharif; G A Arreaza; P Zucker; Q S Mi; J Sondhi; O V Naidenko; M Kronenberg; Y Koezuka; T L Delovitch; J M Gombert; M Leite-De-Moraes; C Gouarin; R Zhu; A Hameg; T Nakayama; M Taniguchi; F Lepault; A Lehuen; J F Bach; A Herbelin
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

6.  CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.

Authors:  Edward E S Nieuwenhuis; Tetsuya Matsumoto; Mark Exley; Robbert A Schleipman; Jonathan Glickman; Dan T Bailey; Nadia Corazza; Sean P Colgan; Andrew B Onderdonk; Richard S Blumberg
Journal:  Nat Med       Date:  2002-06       Impact factor: 53.440

7.  A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.

Authors:  K Miyamoto; S Miyake; T Yamamura
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Detection and quantification of beta-2-microglobulin using mass spectrometric immunoassay.

Authors:  K A Tubbs; D Nedelkov; R W Nelson
Journal:  Anal Biochem       Date:  2001-02-01       Impact factor: 3.365

9.  Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines.

Authors:  Gloria Gonzalez-Aseguinolaza; Luc Van Kaer; Cornelia C Bergmann; James M Wilson; John Schmieg; Mitchell Kronenberg; Toshinori Nakayama; Masaru Taniguchi; Yasuhiko Koezuka; Moriya Tsuji
Journal:  J Exp Med       Date:  2002-03-04       Impact factor: 14.307

10.  Presentation of the same glycolipid by different CD1 molecules.

Authors:  A Shamshiev; H-J Gober; A Donda; Z Mazorra; L Mori; G De Libero
Journal:  J Exp Med       Date:  2002-04-15       Impact factor: 14.307

View more
  14 in total

1.  Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer.

Authors:  Tonya J Webb; Xiangming Li; Robert L Giuntoli; Pablo H H Lopez; Christoph Heuser; Ronald L Schnaar; Moriya Tsuji; Christian Kurts; Mathias Oelke; Jonathan P Schneck
Journal:  Cancer Res       Date:  2012-05-30       Impact factor: 12.701

Review 2.  Immunotherapeutic strategies targeting natural killer T cell responses in cancer.

Authors:  Susannah C Shissler; Dominique R Bollino; Irina V Tiper; Joshua P Bates; Roshanak Derakhshandeh; Tonya J Webb
Journal:  Immunogenetics       Date:  2016-07-08       Impact factor: 2.846

Review 3.  Lipid antigens in immunity.

Authors:  C Marie Dowds; Sabin-Christin Kornell; Richard S Blumberg; Sebastian Zeissig
Journal:  Biol Chem       Date:  2014-01       Impact factor: 3.915

4.  Invariant natural killer T cells generated from human adult hematopoietic stem-progenitor cells are poly-functional.

Authors:  Wenji Sun; Yi Wang; James E East; Amy S Kimball; Katherine Tkaczuk; Susan Kesmodel; Scott E Strome; Tonya J Webb
Journal:  Cytokine       Date:  2015-01-05       Impact factor: 3.861

Review 5.  Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.

Authors:  Wenji Sun; Priyanka B Subrahmanyam; James E East; Tonya J Webb
Journal:  J Interferon Cytokine Res       Date:  2012-10-10       Impact factor: 2.607

Review 6.  Nanoengineering approaches to the design of artificial antigen-presenting cells.

Authors:  Joel C Sunshine; Jordan J Green
Journal:  Nanomedicine (Lond)       Date:  2013-07       Impact factor: 5.307

7.  Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Authors:  Xiangming Li; Masakazu Fujio; Masakazu Imamura; Douglass Wu; Sandhya Vasan; Chi-Huey Wong; David D Ho; Moriya Tsuji
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-02       Impact factor: 11.205

8.  A potent adjuvant effect of a CD1d-binding NKT cell ligand in human immune system mice.

Authors:  Xiangming Li; Jing Huang; Izumi Kaneko; Min Zhang; Shiroh Iwanaga; Masao Yuda; Moriya Tsuji
Journal:  Expert Rev Vaccines       Date:  2016-11-16       Impact factor: 5.217

9.  Development of a qPCR method to rapidly assess the function of NKT cells.

Authors:  Silke Sohn; Irina Tiper; Emily Japp; Wenji Sun; Katherine Tkaczuk; Tonya J Webb
Journal:  J Immunol Methods       Date:  2014-04-12       Impact factor: 2.303

10.  Generation of Human iNKT Cell Lines.

Authors:  Xiangming Li; Moriya Tsuji; Jonathan Schneck; Tonya J Webb
Journal:  Bio Protoc       Date:  2013-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.